Professor of Hematology
Centre for Cancer Biomarkers CCBIO, Department of Clinical Science,
University of Bergen
Senior Consultant, Department of Internal Medicine, Hematology Section, Haukeland University Hospital, Bergen, Research Chief, Helse Bergen, Haukeland universitetssjukehus, Forskings- og utviklingsavdelinga, Postboks 1400, 5021 Bergen, Norway
Visit: Helse Bergen, Haukelandsveien 22, 5021 Bergen, Norway
Bjørn Tore Gjertsen, MD, PhD. is Professor of Hematology from 2007 at Department of Clinical Science at the University of Bergen, working as Research Chief and Consultant Hematologist at Helse Bergen Health Trust, developing early phase clinical trials at Haukeland University Hospital. In 2016 Gjertsen was appointed co-director for Centre for Cancer Biomarkers (CCBIO) Norwegian Centre of Excellence, University of Bergen. His major research interest is development of targeted therapy and accompanying diagnostics in the aggressive blood cancer acute myeloid leukemia. His laboratory is working on intracellular signal transduction and its regulation of the tumor suppressor protein p53. Single cell signaling and immune profiling by multiplexing mass cytometry has been developed for monitoring of immuno- and signaling-directed therapy and is currently used for therapy development of various cancers and myeloid leukemias.